Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity
admin Eli Lilly & Co. Inc.’s LLY, -2.57% steady transformation into a developer of both cutting-edge…
Read Morelife sciences
20 dividend stocks that may be safest if the Federal Reserve causes a recession
Investors cheered when a report last week showed the economy expanded in the third quarter…
Read More‘Shrinkflation’ in ACA health plans narrows provider networks
A little boy’s love of the monkey bars recently became a test of his health…
Read MoreThis reliable indicator of recession has yet to buckle, and so the Fed won’t either, strategist says
As the Fed kicks off its two-day interest-rate setting meeting, the focus is on whether…
Read MoreHerbalife puts former CEO back in charge and withdraws guidance; stock slides
Shares of Herbalife Nutrition Ltd. slid Monday after the nutrition marketer pulled its full-year outlook…
Read MoreWall Street is being nicer on earnings as vaccine makers, fintech reports near
With a downcast earnings season passing the halfway mark, results from financial-technology and vaccine makers…
Read MoreSanofi posts higher sales but $2.07 billion net profit misses forecasts
Sanofi SA on Friday posted higher sales for the third quarter, though net profit declined…
Read More20-year-old investor who made $110 million on a meme stock is pushing for change at a psychedelics company
The 20-year-old investor who found fame this year when he made $110 million trading shares…
Read MoreWith highly concentrated cannabinoids, BioHarvest takes aim at medical and dietary-supplement markets
Canadian and Israeli microcap biotech company BioHarvest Sciences Inc. has launched the first cannabis and…
Read More
20 dividend stocks that may be safest if the Federal Reserve causes a recession
Investors cheered when a report last week showed the economy expanded in the third quarter…
Read More